Position in AMGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,409,371
+$85,712 QoQ
Shares Held
3,892
+3.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#1,472
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cheviot Value Management, LLC holds $85,375,796 across 9 Drug Manufacturers - General names. AMGN ranks #5 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
154,695 | $39,287,889 | |
| 2 | MRK |
Merck & Co., Inc.
|
171,084 | $21,984,294 | |
| 3 | PFE |
Pfizer Inc
|
612,610 | $14,751,648 | |
| 4 | ABBV |
AbbVie Inc.
|
27,894 | $7,019,246 | |
| 5 | AMGN |
Amgen Inc
This page
|
3,892 | $1,409,371 | |
| 6 | LLY |
ELI LILLY & Co
|
581 | $696,868 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,125 | $122,442 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
737 | $93,112 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,409,371 | 3,892 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,323,659 | 3,762 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,231,340 | 3,762 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,061,636 | 3,762 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,050,388 | 3,762 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,172,051 | 3,762 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $979,485 | 3,758 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,210,865 | 3,758 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,175,436 | 3,762 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,065,347 | 3,747 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,079,210 | 3,747 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,074,233 | 3,997 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $887,413 | 3,997 | Shares | Sole | 2023-11-07 | |
| 2023-03-31 | $963,373 | 3,985 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $969,666 | 3,692 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $832,176 | 3,692 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $898,263 | 3,692 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $892,799 | 3,692 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $447,015 | 1,987 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $422,535 | 1,987 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $485,306 | 1,991 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $495,380 | 1,991 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $439,377 | 1,911 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $414,534 | 1,631 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $395,773 | 1,678 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $340,789 | 1,681 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||